XML 175 R57.htm IDEA: XBRL DOCUMENT v3.24.3
EQUITY METHOD INVESTMENTS (Details Narrative)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
EUR (€)
Sep. 30, 2024
USD ($)
Sep. 30, 2024
CAD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
EUR (€)
Dec. 31, 2023
USD ($)
Dec. 31, 2023
CAD ($)
Dec. 31, 2022
USD ($)
Gain on extinguishment of debt $ 0 $ 706   $ 0   $ 1,911,476   $ 1,910,967   $ 1,004,124
Cosmo Farmacy LP [Member]                    
Initial share capital | €     € 150,000       € 150,000      
Initial share capital increased | €     500,000       500,000      
Pharmacy license value | €     € 350,000       € 350,000      
Maturity period of license     30 years 30 years 30 years   30 years 30 years 30 years  
Ownership equity 70.00%     70.00%       70.00%    
Cash contributed to limited partner | €     € 150,000       € 150,000      
Equity ownership remaining 30.00%     30.00%       30.00%    
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member]                    
Upfront cash received         $ 2,000,000       $ 2,000,000  
Fair value of settlement account       $ 1,554,590       $ 1,554,590    
Gain on extinguishment of debt       $ 1,554,590       $ 1,554,590    
Agreement term     five (5) years five (5) years five (5) years   five years five years five years  
Cash received upon gross sales         $ 2,750,000       $ 2,750,000  
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales One [Member]                    
Cash received upon gross sales         2,750,000       2,750,000  
Gross sales         13,000,000       13,000,000  
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]                    
Cash received upon gross sales         2,750,000       2,750,000  
Gross sales         $ 6,500,000          
Marathon Global Inc [Member] | Distribution and Equity Acquisition Agreement [Member] | Gross Sales [Member]                    
Gross sales                 $ 6,500,000  
Share Exchange Agreement [Member] | ICC [Member]                    
Investement $ 167,175     $ 167,175       $ 165,930   $ 160,470